Warning: include_once(../article_type.php): failed to open stream: No such file or directory in /home/suxhorbncfos/public_html/omcij/OMCIJ.MS.ID.555740.php on line 124
Warning: include_once(): Failed opening '../article_type.php' for inclusion (include_path='.:/opt/alt/php56/usr/share/pear:/opt/alt/php56/usr/share/php') in /home/suxhorbncfos/public_html/omcij/OMCIJ.MS.ID.555740.php on line 124
Isolation and Microbial Screening of 1-Methylcyclopentene from Bracystelma
Abiche Ekalu1*, Rachael Gbekele-Oluwa Ayo2, James D Habila2 and Ibrahim Hamisu2
1Nigerian Army School of Education, Nigeria
2Ahmadu Bello University Zaria, Kaduna, Nigeria
Submission: May 09, 2019; Published: May 29, 2019
*Corresponding author: Abiche Ekalu, Nigerian Army School of Education, Ilorin, Kwara, Nigeria
How to cite this article: Abiche Ekalu, Rachael Gbekele-Oluwa Ayo, James D Habila, Ibrahim Hamisu. Isolation and Microbial Screening Of
1-Methylcyclopentene From Bracystelma Togoense Schtlr. Organic & Medicinal Chem IJ. 2019; 8(3): 555740 DOI: 10.19080/OMCIJ.2019.08.555740
The secondary metabolites, 1-methylcyclopentene was isolated from the CH2Cl2 extract of Brachystelma togoense used traditionally for treatment of ailments. The structure was elucidated using 1H, 13C and 2D NMR. 1-methylcyclopentene previously undescribed from plant sources had shown various biological activities S. aureus, E. coli, S. pneumonia, S. typhi, and C. albicans. It was observed that 1-methylcyclopentene was more active against C. albicans (24mm) and E. coli (20mm). 1-methylcyclopentene also showed the highest activity against E. coli (0.1875 mg/mL) and C. albicans (0.1875 mg/mL). The MBC/MFC was observed for E. coli (0.75 mg/mL), S. pneumonia (0.75 mg/mL), S. typhi (0.75 mg/mL) and C. albicans (0.375 mg/mL) respectively. The activity of 1-methylcyclopentene in B. togoense justified ethnomedicinal uses of the plant.
Keywords: Phyto Chemical 1-methylcyclopentene Brachystelma togoense Schtlr
Medicinal plants are used in developing countries as alternative medical treatments and extracts and essential oils isolated from these plants have shown biological activity in vitro and in vivo . Mankind has explored herbal medicines for relieving pain and to cure various diseases for the last 60,000 years . Nowadays, more than 50% of natural drugs being used for medication, are of plant origin [2,3]. According to the World Health Organization (WHO), about 80% of the world’s population use herbs and other traditional medicines for their primary healthcare and three kinds of herbal medicines are used: raw plant materials, processed plant materials and herbal products . Herbal medicines are natural products that have proved to be safe, both due to their low side-effects while being used to treat diseases and also acting at the same time as dietary supplements preventing the human body from such diseases. Many of the Tuberous Brachystelma are known to be used medicinally for the treatment of headache, stomachache and colds in children. In China, Brachystelma edule tubers are edible and the plant is used for the treatment of coughs and reduction of phlegm .
The stem bark of brachystelma togoense was collected in April 2018 from Benue State, Nigeria. The plant was identifiedby the plant taxonomist Mallam Sanusi Namadi and a voucher specimen (no. 25856) is retained in Biological Science Depatment, Ahmadu Bello University, Zaria-Nigeria
The air-dried B. togoense was manually reduced to powder using mortar and pestil. Exactly 1000 g of the powdered plant material was extracted on a shaker at room temperature using 100 % dichloromethane (CH2Cl2) for 72h. The extracts were concentrated using a rotary evaporator at 40°C resulting in a brown gum-like texture (32g). The CH2Cl2 extract was separated by flash chromatography (Biotage SP1) over silica gel using three solvents. Firstly, a hexane/ CH2Cl2, gradient starting with 100% hexane and gradually increasing the polarity to 100 % CH2Cl2. Secondly, CH2Cl2 /EtOH/Ac from a 100% CH2Cl2 to 50% EtOH/Ac and to 100 % EtOH/Ac to yield various fractions (fr. 1-100). Fr.5 was spotted on the TLC plate using 100% CH2Cl2 and appeared a pure compound 1 (70.0mg).
Compound 1 was isolated as a cream solid from the CH2Cl2extract of the aerial parts of Brachystelma togoense and identified as the 1-methylcyclopentene, which is being reported for the first time from plant source. However, 1-methylcyclopentene has been reported from the CH2Cl2 extractof Iridomyrmex discors (ants) (6). The IR spectrum (spectrum
1-4) showed absorbance bands for aliphatic methylene (3054
and 1422 cm-1) and sp3 CH (2987 and 1375 cm-1) groups.
The 13C NMR spectrum (spectrum 3) showed six resonances
including two alkene carbon resonances at δC 135.1 (C-1) and
124.4 C-2). The three carbon resonances (δC 40.0, δC 29.9,
δC 26.9) and a vinyl methyl group resonance (δC16.3) whose
corresponding methyl group proton resonance occurred at δH
1.53s). The COSY spectrum (spectrum 5-7) showed correlations
between the H-2 and two H-3 resonances and also long-range
coupling with the 3H-6 resonances. Coupling was seen between
methylene protons. This compound has been isolated before
 but not from plants. The 1H and 13C NMR resonances wereassigned using HSQC and HMBC spectra and are given in Table 1
the structure of compound 1 is shown in (Figure 1).
The microorganisms tested were: Staphylococcus aureus,
Streptococcus pneumoniae, Escherichia coli, Salmonella typhi, and
Candida albicans. They were obtained from the Department of
Medical Microbiology, Ahmadu Bello University Teaching Hospital
(ABUTH), Shika, Zaria. All the isolates were checked for purity
and maintained in nutrient agar slant (Figure 2).
The standardized inocula of the isolates were uniformly
streaked unto freshly prepared Mueller Hinton agar plates with
the aid of a sterile swab stick. Using a sterile cork borer (6 mm in
diameter), 5 appropriately labeled wells were punched into each
agar plate. Aliquot of 0.3mL of the appropriate isolate concentration
was placed in each well and then allowed to diffuse into the
agar. An extra plate was streaked with the isolate and ciprofloxacin
(10μ/disc) was placed on it. The plates were incubated at
37°C for 24h. While for the fungi, Sabouraud dextrose broth was
used and the incubation period was 30°C and 48h. The antimicrobial
activities were expressed as diameter (mm) of inhibition
zones produced by the plant extracts spectrum 8.
The minimum inhibition concentrations of the isolates were
carried out on the test microbes using the broth dilution method
as outlined by the Clinical and Laboratory Standards Institute
. Mueller Hinton broth was prepared; 10mL was dispensedinto tubes and was sterilized at 121°C for 15 minutes and allowed
to cool. The McFarland turbidity standard scale 0.5 was
prepared to give turbidity solution. Normal saline was prepared,
10mL was dispensed into sterile test tube and the test microbes
was inoculated and incubated at 37°C for 24 hours. Dilution of
the test microbes was done in the normal saline until the turbidity
marched that of the Mc-Farland turbidity scale by visual
comparison at this point the test microbe has a concentration of
about 1.5x108 cfu/mL. Two-fold serial dilution of the extracts in
the sterilized broth was made to obtain the concentrations of 3
mg/mL, 1.5 mg/mL, 0.75 mg/mL, 0.375 mg/mL, 0.1875 mg/mL
and 0.09375 mg/mL. The initial concentration was obtained by
dissolving 6 mg of the isolate in 10 mL of the sterile broth. Having
obtained the different concentrations of the extracts in the
sterile broth, 0.3 mL of the standard inoculum of the test microbe
in the normal saline was then inoculated into the different concentrations.
Incubation was made at 37 °C for 24h, after which
each test tube of the broth was observed for turbidity (growth).
The lowest concentration of the extract in which the broth shows
no turbidity was recorded as the Minimum Inhibition Concentration
Determination of Minimum Bactericidal Concentration/
Minimum Fungicidal Concentration (MBC/MFC)
The minimum bactericidal concentration of the extracts
was determined as outlined by the CLSI on the nutrient agar
plates. Minimum bactericidal concentrations were determined
by assaying the test tube contents of the MIC determinations. A
loopful of the content of each tube was inoculated by streaking
on a solidified nutrient agar plate and then incubated at 37°C
for 24h for bacterial and 30°C for 48h for fungi. After which it
was observed for microbial growth. The lowest concentration
of the subculture with no growth was considered as minimumbactericidal concentration/ minimum fungicidal concentration
The secondary metabolites, 1-methylcyclopentene was isolated
from the CH2Cl2 extract of Brachystelma togoense used traditionally
for treatment of ailments. The structure was elucidated
using 1H, 13C and 2D NMR. 1-methylcyclopentene previously
undescribed from plant sources had shown various biological
activities S. aureus, E. coli, S. pneumonia, S. typhi, and C. albicans.
It was observed that 1-methylcyclopentene was more active
against C. albicans (24mm) and E. coli (20 mm). 1-methylcyclopentene
also showed the highest activity against E. coli (0.1875
mg/mL) and C. albicans (0.1875 mg/mL). The MBC/MFC was observed
for E. coli (0.75 mg/mL), S. pneumonia (0.75 mg/mL), S.
typhi (0.75 mg/mL) and C. albicans (0.375 mg/mL) respectively.
The activity of 1-methylcyclopentene in B. togoense justified ethnomedicinal
uses of the plant.